Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lotte Vanherle

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|August 15, 2022
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammationFranziska E Uhl, Lotte Vanherle, Anja Meissner
International Journal of Molecular Sciences|January 31, 2019
T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated ChemotaxisNicholas Don-Doncow, Lotte Vanherle, Yun Zhang, et al.
International Journal of Molecular Sciences|January 21, 2022
Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart FailureFranziska E Uhl, Lotte Vanherle, Frank Matthes, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 5, 2023
Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lungLotte Vanherle, Frank Matthes, Franziska E Uhl, et al.
Frontiers in Cell and Developmental Biology|March 3, 2020
Improving Cerebrovascular Function to Increase Neuronal Recovery in Neurodegeneration Associated to Cardiovascular DiseaseLotte Vanherle, Hana Matuskova, Nicholas Don-Doncow, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Sphingosine-1-Phosphate, a Marker of Endothelial Injury and Disease Severity in PreeclampsiaCamilla Edvinsson, Federica Piani, Frank Matthes, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2021
Plasma S1P (Sphingosine-1-Phosphate) Links to Hypertension and Biomarkers of Inflammation and Cardiovascular Disease: Findings From a Translational InvestigationAmra Jujic, Frank Matthes, Lotte Vanherle, et al.
Life Sciences|September 6, 2025
Subcutaneous administration of the sphingosine kinase 2 inhibitor ABC294640 has no metabolic benefits in high fat diet-induced obesity in male miceCecilia Skoug, Lotte Vanherle, Lisa Teresa Porschen, et al.
NPJ Aging and Mechanisms of Disease|August 5, 2021
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemiaNicholas Don-Doncow, Lotte Vanherle, Frank Matthes, et al.
Aging and Disease|October 24, 2025
Sphingosine Kinase 2 Inhibition Ameliorates Neuroinflammation in Diet-Induced Obese MiceLotte Vanherle, Cecilia Skoug, Lisa Teresa Porschen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|August 15, 2022
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammationFranziska E Uhl, Lotte Vanherle, Anja Meissner
International Journal of Molecular Sciences|January 31, 2019
T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated ChemotaxisNicholas Don-Doncow, Lotte Vanherle, Yun Zhang, et al.
International Journal of Molecular Sciences|January 21, 2022
Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart FailureFranziska E Uhl, Lotte Vanherle, Frank Matthes, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 5, 2023
Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lungLotte Vanherle, Frank Matthes, Franziska E Uhl, et al.
Frontiers in Cell and Developmental Biology|March 3, 2020
Improving Cerebrovascular Function to Increase Neuronal Recovery in Neurodegeneration Associated to Cardiovascular DiseaseLotte Vanherle, Hana Matuskova, Nicholas Don-Doncow, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Sphingosine-1-Phosphate, a Marker of Endothelial Injury and Disease Severity in PreeclampsiaCamilla Edvinsson, Federica Piani, Frank Matthes, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2021
Plasma S1P (Sphingosine-1-Phosphate) Links to Hypertension and Biomarkers of Inflammation and Cardiovascular Disease: Findings From a Translational InvestigationAmra Jujic, Frank Matthes, Lotte Vanherle, et al.
Life Sciences|September 6, 2025
Subcutaneous administration of the sphingosine kinase 2 inhibitor ABC294640 has no metabolic benefits in high fat diet-induced obesity in male miceCecilia Skoug, Lotte Vanherle, Lisa Teresa Porschen, et al.
NPJ Aging and Mechanisms of Disease|August 5, 2021
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemiaNicholas Don-Doncow, Lotte Vanherle, Frank Matthes, et al.
Aging and Disease|October 24, 2025
Sphingosine Kinase 2 Inhibition Ameliorates Neuroinflammation in Diet-Induced Obese MiceLotte Vanherle, Cecilia Skoug, Lisa Teresa Porschen, et al.
Pageof 2